These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27626309)

  • 1. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
    Morrison CD; Allington TM; Thompson CL; Gilmore HL; Chang JC; Keri RA; Schiemann WP
    Oncotarget; 2016 Nov; 7(45):72777-72794. PubMed ID: 27626309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers.
    Morrison CD; Chang JC; Keri RA; Schiemann WP
    Cell Death Dis; 2017 Jun; 8(6):e2899. PubMed ID: 28661474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
    Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
    J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
    Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
    Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABL tyrosine kinase inhibition variable effects on the invasive properties of different triple negative breast cancer cell lines.
    Chevalier C; Cannet A; Descamps S; Sirvent A; Simon V; Roche S; Benistant C
    PLoS One; 2015; 10(3):e0118854. PubMed ID: 25803821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
    Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
    J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
    Neil JR; Tian M; Schiemann WP
    J Biol Chem; 2009 Aug; 284(32):21209-17. PubMed ID: 19531477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.
    Chiche A; Moumen M; Romagnoli M; Petit V; Lasla H; Jézéquel P; de la Grange P; Jonkers J; Deugnier MA; Glukhova MA; Faraldo MM
    Oncogene; 2017 Apr; 36(17):2355-2365. PubMed ID: 27775073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
    Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
    Zupanska A; Adach A; Dziembowska M; Kaminska B
    Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells.
    Zhao C; Meng L; Hu H; Wang X; Shi F; Wang Y; Li Q; Lin A
    BMC Cell Biol; 2010 Oct; 11():82. PubMed ID: 20969773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
    Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
    Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of BCCIP deficiency in mammary tumorigenesis.
    Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
    Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.